Table 3.
Adherence measure | Host, n (%) | Refugee, n (%) | p valuea |
---|---|---|---|
Dose-by-dose self-report (four days) | (n = 148) | (n = 153) | 0.20 |
0+ | 6 (4) | 11 (7) | |
80+ | 0 (0) | 1 (1) | |
95+ | 142 (96) | 141 (92) | |
Visual analogue scale self-report (one month) | (n = 148) | (n = 153) | 0.79 |
0+ | 11 (7) | 11 (7) | |
80+ | 33 (22) | 32 (21) | |
95+ | 104 (70) | 110 (72) | |
Pharmacy claim adherence (24 months)b | (n = 143) | (n = 136) | 0.15 |
0+ | 14 (10) | 9 (7) | |
80+ | 34 (24) | 26 (19) | |
95+ | 95 (66) | 101 (74) |
aChi-square test for trend (Cochran–Armitage test)
bSince started on HAART to a maximum of 24 months, retrospectively